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ABSTRACT
Severe dengue cases have increased in Brazil since 2001, with the first records in 
Maranhão dating back to 2002. The aim of this study was to determine the prevalence of 
severe dengue cases by age group and the possible risk factors. This was a study of secondary 
data on dengue in residents of São Luís, Maranhão, Brazil, using probable cases notified to 
the National Mandatory Reporting System (SINAN) from 2002 to 2011. The diagnosis and 
classification of dengue were based on the Brazilian Ministry of Health criteria: dengue fever 
(DF), dengue hemorrhagic fever (DHF) and dengue fever with complications (DWC). DHF 
and DWC were considered severe dengue, and DF was classified as non-severe dengue. A 
logistic regression analysis was performed with severe dengue as the outcome. During the 
study period, 1,229 cases of severe dengue were reported; of these, 812 in patients under 
the age of 15 (66%). Among the risk factors evaluated, age under 15 years old (OR = 3.10, 
95% CI = 2.69-3.57, p-value = 0.001) was associated with severe dengue. The prevalence 
of severe dengue in children under the age of 15 was higher, and only this age group was 
associated with the occurrence of severe dengue.
KEYWORDS: Severe dengue. Children. Public health surveillance. Risk factors. Dengue 
complications. Dengue clinical severity.
INTRODUCTION
The World Health Organization (WHO) estimates that 40% of the world’s 
population lives in areas endemic to dengue virus1. The clinical spectrum of the 
disease varies from asymptomatic infection to severe conditions2. Dengue infection 
is a serious public health problem both because of the spread of the disease, on a 
worldwide scale, and because of the increase in severe cases and deaths3. 
Occurrence of severe dengue cases is associated with factors related to the host 
(age, phenotype, presence of comorbidities, immunogenetic profile, sequential 
infection), to the etiological agent (serotype, strain, genotype), and to environmental 
aspects favoring the vector proliferation4-7.
In Americas, Brazil and Mexico account for approximately 14% of the severe 
dengue cases, which is equivalent to the proportion of the entire African continent8. 
During the 2007 epidemic in Brazil, a change in the age distribution of dengue was 
reported, with an increase in the burden on children that year. Of the 2,706 dengue 
hemorrhagic fever cases in 2007, 1,710 (63.2%) were reported from the Northeast 
region; 1,119 (65.4%) of these were in children <15 years old9.
In São Luís, the capital of the State of Maranhão, dengue cases hemorrhagic 
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fever and dengue deaths were detected for the first time in 
200210. In Maranhão, the number of severe cases increased 
from 50 in 2009 to 185 in 201011.
The present study analyzed the prevalence of severe 
dengue by comparing the number of dengue cases in two 
age groups, patients <15 years old and patients >15 years 
in São Luís, Maranhão, from 2002 to 2011. This study 
aimed to answer the following question: in São Luís, was 
the occurrence of dengue more frequent and more severe 
in children under 15 years old?
MATERIALS AND METHODS
This population-based study used an analytical and 
descriptive approach of secondary data on probable dengue 
cases notified to the National Mandatory Reporting System 
(SINAN) in residents of São Luís, Maranhão, Brazil. All 
probable dengue cases from the period of 2002 to 2011 
were included.
Comparing data from the last two census of the Brazilian 
Institute of Geography and Statistics (IBGE) - 2000 
and 2010, São Luís population increased from 857,387 
inhabitants to 1,015,837; the urban population decreased 
from 96,17% to 94,45%; the population of inhabitants 
under 15 years old decreased from 260,426 (30.37%) 
to 240,467 (23,70%) and the proportion of people with 
monthly per capita household income inferior to US$ 44. 
dropped from 34.90% in 2000 to 13,81% in 201012. In 
the period of this study, the Brazilian Ministry of Health 
adopted the WHO dengue case classification: dengue 
fever and dengue hemorrhagic fever13, adapted with the 
inclusion of an additional category: dengue fever with 
complications14. Dengue fever is defined as a suspected 
case - an acute febrile illness (fever up to 7 days of duration) 
accompanied by at least two of the following clinical 
findings: nausea, vomiting, headache, arthralgia, retro-
orbital pain, rash, myalgia, hemorrhagic manifestations 
and leukopenia confirmed by laboratory tests or, during an 
epidemic, confirmed by clinical-epidemiological criteria. 
The definition of dengue hemorrhagic fever consists in 
the presence of all of the five following criteria: fever (up 
to 7 days of duration), evidence of bleeding (spontaneous 
bleeding or a positive tourniquet test), thrombocytopenia 
< 100,000 cells/mm3, plasma leakage evidence (pleural 
effusion, ascites, hypoalbuminemia or hemoconcentration 
greater than 20% from baseline) and at least one positive 
test for dengue: detection of dengue virus nonstructural 
protein 1 (NS1) by using ELISA, IgM antibody capture 
enzyme-linked immunosorbent assay (MAC-ELISA), viral 
isolation or reverse transcription-polymerase chain reaction 
(RT-PCR). Dengue fever with complications is defined as 
any severe case that does not fit the WHO criteria for dengue 
hemorrhagic fever and when the classification of dengue 
fever is unsatisfactory, that is, when one of the following 
complications is found: severe nervous system disorders, 
cardiorespiratory dysfunction, liver failure, gastrointestinal 
bleeding, cavitary effusion, thrombocytopenia = 20,000/mm3, 
leukopenia = 1,000/mm3, and suspected dengue with 
progression to death that does not fit completely the dengue 
hemorrhagic fever criteria14. 
The tests used for laboratory confirmation of the 
cases were: MAC-ELISA, RT-PCR, NS1 ELISA, 
immunohistochemistry and histopathology, the last two 
used in death cases.
STATA® version 14.0 (Stata Corporation, College 
Station, TX, USA) was used for the statistical analysis. 
In the descriptive analysis, the qualitative variables were 
presented as absolute frequencies and proportions. For 
the quantitative variables, measures of central tendency 
and dispersion were calculated. Two categorical variables 
were created in the statistical analysis: severe dengue and 
non-severe dengue based on the final case classification in 
the SINAN form. Dengue hemorrhagic fever and dengue 
fever with complications were classified as severe dengue, 
and dengue fever was classified as non-severe dengue. To 
test the association between the variables, the chi-square 
test was used. To analyze the associated factors, we used a 
logistic regression model. The outcome was severe dengue 
and the co-variables included were gender, race/skin color, 
area of residence and age group (<15 years old and >15 
years old). The inclusion of these variables on the model 
derives from the fact that in the literature female gender15, 
caucasian phenotype16,17 and children <15 years old18 are 
reported as risk factors to severe dengue. The odds ratios 
and respective 95% confidence intervals were estimated.
The case-fatality rate over a year was calculated by 
dividing the number of deaths by the number of severe 
cases.
RESULTS
Notification of dengue cases is based on clinical 
suspicion. After investigation of the notified suspected 
cases, they are classified as discarded or probable. Although 
this study data refer to probable cases from 2002 to 2011, 
on SINAN, only 397 records from 2007 to 2010 related to 
the number of discarded cases were available regarding the 
residents of São Luís. 
Severe dengue cases of São Luís residents were first 
reported in 2002. From 2002 to 2011, there were 14,780 
probable dengue cases, of which 1,229 (7.09%) were severe. 
Of these, 812 (66.07%) were in children under 15 years old 
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(6.9 ± 3.4 years) and 417 (33.93%) were in patients >15 
years old (33.1 ± 14.5 years). There was a predominance 
of females, people with mixed ethnicity and residents in 
the urban area, regardless of age and severity. The lowest 
values for platelet count were found in patients with severe 
dengue, irrespective of the age group (Table 1).
Among the cases classified as dengue fever with 
complications, the most frequent criteria were cavitary 
effusions and platelet count <20,000/mm3 in both age 
groups; gastrointestinal bleeding was found in 11 children 
under 15 years old and in seven people who were >15 years 
old; cardiorespiratory complications were found in four 
cases in each age group and neurological complications 
were found in seven children under 15 years old and in 
one in the group >15. In the criterion “does not fit dengue 
hemorrhagic fever”, there were 62 cases among the patients 
<15 years old and 23 among patients >15. 
There were 532 (43.29%) severe dengue cases and 9,040 
(66.71%) non-severe dengue cases (Table 1) confirmed 
by laboratory criterion. It was not possible to establish 
a proportion of positive/reagent results for each exam, 
because frequently the information was missing when the 
exam was not made or the result was negative/non-reagent.
The viral serotype was identified in 47 patients 
(Table 2). Among the severe dengue cases, there was a 
higher occurrence of isolation of DENV-1 (12.50%) and 
DENV-2 (87.50%) serotypes in patients < 15 years old and 
of DENV-3 (57.14%) and DENV-2 (28.57%) serotypes in 
patients > 15. There was no viral isolation in 2005, 2006 
or 2009. In the years 2007 and 2011, the simultaneous 
circulation of three serotypes was detected: DENV-1, 
DENV-2 and DENV-3 in 2007 and DENV-1, DENV-2 and 
DENV-4 in 2011. DENV-1 was not isolated in individuals 
>15 with severe dengue. DENV-2 was detected in both 
Table 1 - Sociodemographic, clinical and laboratory characteristics of dengue cases, according to age group and clinical severity. 
São Luís, Maranhão, 2002 to 2011
Characteristics
< 15 years old ≥ 15 years old
Severe dengue Non-severe dengue Severe dengue Non-severe dengue
n % n % n % n %
Gender 812 100.00 5,316 100.00 417 100.00 8,235 100.00
Male 380 46.80 2,657 49.98 190 45.45 3,771 45.79
Female 432 53.20 2,659 50.02 228 54.55 4,464 54.21
Race/skin color 673 100.00 3,823 100.00 334 100.00 5,813 100.00
White 148 22.00 591 15.50 69 20.65 1,099 18.90
Black 37 5.49 184 4.80 22 6.60 493 8.46
Asian 2 0.30 68 1.77 8 2.40 110 1.90
Mixed 485 72.06 2,975 77.80 235 70.35 4,095 70.44
Indigenous 1 0.15 5 0.13 0 0.00 16 0.30
Area 755 100.00 5,097 100.00 391 100.00 7,941 100.00
Urban 667 88.34 4,710 92.41 370 94.63 7,458 93.92
Rural/Periurban 88 11.66 387 7.59 21 5.37 483 6.08
Final classification 812 100.00 5,316 100.00 417 100.00 8,235 100.00
DF 0 0.00 5,316 100.00 0 0.00 8,235 100.00
DWC 618 76.11 0 0.00 326 78.18 0 0.00
DHF 194 23.89 0 0.00 91 21.27 0 0.00
Confirmation criterion 589 100.00 4,944 100.00 267 100.00 7,745 100.00
Laboratorial 349 59.25 1,475 29.83 193 72.28 2,174 28.07
Clinical-epidemiological 240 40.75 3,469 70.17 74 27.72 5,571 71.93
Platelets/mm3, n 499 72 174 116
Mean±SD 51,255.78±45,375.01 67,258.33±39,044.30 45,199.48±39,445.23 84,421.55±53,175.76
Hematocrit (%), n 62 136 77 313
Mean±SD 39.17±4.64 38.23±5.67 40.73±6.26 40.12±5.82
DF = dengue fever, DWC = dengue fever with complications, DHF = dengue hemorrhagic fever. Source: SINAN.
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age groups, regardless of clinical severity. DENV-3 was 
not isolated in children <15 years old with severe dengue. 
DENV-4 was not isolated in children <15 years old.
There was a higher frequency of severe cases in 
2007, with 630 cases (51.26%), and a particularly high 
proportion in children under 15 years old (60.71%). 
Likewise, there were 225 severe cases (20.35%) in 2011. 
Most cases occurred in the period from April to August. 
Most hospitalizations of severe cases occurred in May 
whereas most hospitalizations of non-severe cases occurred 
in August, regardless of age. The monthly distribution 
of hospitalization of the total study period follows the 
distribution of hospitalization months in the years with the 
highest absolute numbers of cases: 2005, 2007, 2010 and 
2011 (Table 3).
The first deaths occurred in 2002, concomitantly with 
the first records of severe dengue. In total, there were 58 
deaths, 32 of which were of patients under 15 years old. 
There was an abrupt increase in the number of deaths in 
children under 15 years old in 2007, and there were high 
case-fatality rates, particularly in 2005 and in 2007 in 
children under 15 (Figure 1). Among the 47 patients in 
whom the serotype was identified, 8 (17.02%) died. 
The most frequent clinical manifestations were 
severe abdominal pain (72.86%), petechia (66.43%) and 
gastrointestinal bleeding (25.93%); these symptoms were 
predominant in children <15 years old (Table 4).
In the univariate analysis, there was a significant 
association between severe dengue and age <15 years 
old, caucasian skin color and urban area of residence, but 
the association with gender was not significant. In the 
multivariate analysis, there’s only the association with age 
<15 years old (Table 5).
DISCUSSION
In 2009, the WHO issued the revised dengue 
classification: dengue without warning signs, dengue with 
warning signs (abdominal pain, persistent vomiting, fluid 
accumulation, mucosal bleeding, lethargy, restlessness, 
liver enlargement, increasing hematocrit with decreasing 
platelets) and severe dengue (severe plasma leakage, severe 
bleeding or organ failure)19. It was only from 2014 that the 
Brazilian Ministry of Health started to use the revised WHO 
dengue classification. In the first study in Brazil to evaluate 
the revised WHO classification criteria, Lima et al.20 
conducted a cross-sectional survey to evaluate the ability 
of the 1997 and 2009 WHO classification systems to detect 
severe dengue cases based on the medical records of dengue 
patients who were admitted to the University Hospital of the 
Federal University of Grande Dourados, Mato Grosso do 
Sul State, in the summers of 2009 and 2010. They reported 
that, of the 150 patients classified as having dengue fever, 
105 (70%) were re-classified as having dengue with warning 
signs or severe dengue. They did not consider the Brazilian 
category dengue fever with complications, whose several 
criteria are included in dengue with warning signs or in 
severe dengue. Otherwise, Cavalcanti et al.21 evaluated the 
revised WHO dengue classification in a retrospective cross-
sectional study of the dengue hemorrhagic fever patients 
who were admitted to São José Hospital in Fortaleza, Ceará 
State, Northeastern Brazil. They also reported 52 patients 
Table 2 - Distribution of the 47 dengue virus serotypes according clinical severity and year of occurrence. São Luís, Maranhão, 
2002 to 2011 
Serotype
Year
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Total
Non-severe dengue
DENV-1 1 1 0 0 0 1 0 0 12 2 17
DENV-2 0 0 0 0 0 2 0 0 0 1 3
DENV-3 3 1 0 0 0 0 0 0 0 0 4
DENV-4 0 0 0 0 0 0 0 0 0 5 5
Severe dengue
DENV-1 0 0 0 0 0 1 0 0 0 0 1
DENV-2 0 0 0 0 0 8 1 0 0 0 9
DENV-3 1 0 3 0 0 2 1 0 0 0 7
DENV-4 0 0 0 0 0 0 0 0 0 1 1
Total 5 2 3 0 0 14 2 0 12 9 47
Source: SINAN.
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Table 3 - Distribution of dengue cases by year and month of occurrence and of hospitalization, according to age group and clinical 
severity. São Luís, Maranhão, 2002 to 2011 
Characteristics
< 15 years old (n=6,128) ≥ 15 years old (n=8,652)
Severe dengue Non-severe dengue Severe dengue Non-severe dengue
n % n % n % n %
Year of occurrence 812 100.00 5,316 100.00 417 100.00 8,235 100.00
2002 6 0.74 182 3,42 16 3.83 351 4.26
2003 4 0.49 120 2.26 30 7.18 448 5.44
2004 2 0.25 25 0.47 5 1.20 129 1.57
2005 24 2.96 134 2.52 43 10.29 248 3.01
2006 35 4.31 57 1.07 3 0.72 215 2.61
2007 493 60.71 1,187 22.33 137 32.78 1,541 18.71
2008 17 2.09 277 5.21 22 5.26 813 9.87
2009 7 0.86 22 0.41 8 1.91 29 0.35
2010 111 13.67 1,242 23.36 41 9.81 1,174 14.26
2011 113 13.92 1,946 36.61 112 26.79 2,855 34.67
Month of occurrence 701 100.00 3,430 100.00 307 100.00 5,436 100.00
Missing 111 13.67 1,886 35.48 110 26.38 2,799 33.99
January 24 2.96 45 0.85 28 6.71 144 1.75
February 20 2.46 85 1.60 22 5.28 241 2.93
March 58 7.14 177 3.33 33 7.91 455 5.53
April 78 9.61 444 8.35 37 8.87 819 9.95
May 105 12.93 553 10.40 58 13.91 965 11.72
June 145 17.86 375 7.05 42 10.07 660 8.01
July 106 13.05 406 7.64 43 10.31 505 6.13
August 83 10.22 622 11.70 24 5.76 786 9.54
September 55 6.77 480 9.03 9 2.16 461 5.60
October 17 2.09 165 3.10 5 1.20 210 2.55
November 8 0.99 45 0.85 5 1.20 118 1.43
December 2 0.25 33 0.62 1 0.24 71 0.86
Year of hospitalization 538 100.00 1,347 100.00 227 100.00 1,577 100.00
2002 2 0.37 25 2.00 10 4.40 37 2.35
2003 3 0.55 39 3.00 25 11.01 108 6.85
2004 2 0.37 12 1.00 4 1.76 40 2.54
2005 20 3.75 72 5.20 31 13.69 86 5.46
2006 32 5.95 46 3.40 3 1.32 61 3.86
2007 336 62.45 0 0.00 66 29.07 0 0.00
2008 14 2.60 0 0.00 14 6.16 0 0.00
2009 5 0.92 0 0.00 5 2.20 0 0.00
2010 66 12.26 680 50.00 21 9.25 452 28.66
2011 58 10.78 473 35.40 48 21.14 793 50.28
Month of hospitalization 524 100.00 1,282 100.00 206 100.00 1,466 100.00
Missing 14 2.60 65 4.83 21 9.25 111 7.04
January 8 1.49 18 1.34 8 3.52 42 2.66
February 18 3.35 41 3.04 10 4.41 54 3.42
March 44 8.18 38 2.82 15 6.61 73 4.63
April 68 12.64 62 4.60 29 12.78 54 3.42
May 94 17.47 98 7.28 48 21.15 152 9.64
June 93 17.29 111 8.24 28 12.33 208 13.19
July 76 14.13 207 15.37 32 14.10 168 10.65
August 60 11.15 382 28.36 21 9.25 450 28.54
September 39 7.25 194 14.40 8 3.52 113 7.17
October 15 2.79 69 5.12 3 1.32 57 3.61
November 7 1.30 44 3.27 3 1.32 53 3.36
December 2 0.37 18 1.34 1 0.44 42 2.66
Source: SINAN.
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classified as dengue fever with complications, of whom 17 
(32.7%) were re-classified as dengue with warning signs 
and 32 (61.5%) as severe dengue. In the present study the 
term “severe dengue” included dengue hemorrhagic fever 
and dengue fever with complications.
We found an association between severe dengue with 
being caucasian/skin color only in the univariate analysis. 
In 1981, in Havana, Kouri et al.5 identified that the majority 
(80.4%) of adults and children who died due to severe 
dengue fever were of white phenotype; this association 
Figure 1 - Distribution of dengue cases according to case-fatality rate, age group and clinical severity. São Luís, Maranhão, 2002 
to 2011
Table 4 - Hemorrhagic manifestations and plasma extravasation according to the age group and clinical severity. São Luís, 
Maranhão, 2002 to 2011 
Clinical characteristics
< 15 years old ≥ 15 years old
Severe Non-severe Severe Non-severe
n/total % n/total % n/total % n/total %
Hemorrhagic manifestations 357/428 74.07 1/1 100.00 111/142 78.17 1/1 100.00
Epistaxis 49/428 11.45 24/620 3.87 35/208 16.83 39/1,713 2.23
Gum bleeding 29/428 6.78 8/623 1.28 37/209 17.70 18/1,762 1.02
Uterine bleeding 11/229 4.80 3/254 1.18 8/123 14.63 17/744 2.28
Petechia 285/428 66.43 66/621 10.63 109/208 52.40 120/1,753 6.85
Hematuria 22/428 5.14 3/500 0.60 19/207 9.18 15/1,331 1.13
Gastrointestinal bleeding 111/428 25.93 7/500 1.40 32/207 15.46 14/1,331 1.05
Positive tourniquet test 152/349 43.55 1/1 100.00 40/207 37.38 1/1 100.00
Plasma extravasation 408/428 95.32 23/620 3.70 85/148 57.43 16/16 100.00
Source: SINAN.
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was statistically significant. An investigation conducted by 
Ayllón et al.17 in 1989 showed that girls of the caucasian 
phenotype were more susceptible to develop severe forms 
even with secondary dengue fever.
There was a three-fold increased chance of developing 
severe dengue in children younger than 15. In Thailand, 
Gamble et al.22 found that 97.4% of severe dengue cases 
occurred in children.
In this study, severe dengue was more frequent in 
females, including those under 15 years old; however, there 
was no significant association between gender and severe 
dengue. A study conducted in Southeast Asia by Ooi et al.23 
showed that female patients were more likely to develop 
severe forms of dengue. In another study also conducted 
in Southeast Asia in 1970, Halsted et al.4 noted that males 
predominated among patients with milder disease, but 
the disease was more severe in females. In a Nicaraguan 
study15 of adults and children who developed severe forms 
of dengue fever, the female/male ratio was 3:2 among adults 
and 1:1 among children.
As predicted by Vasconcelos et al.24 in the classic sero-
epidemiological study of the dengue outbreak that occurred 
in 1995 and 1996 in São Luís, there was a high risk of the 
development of severe forms in the city due to the isolation 
and sensitization of the population to DENV-1. Starting in 
2002, this prediction materialized, and there were epidemics 
with severe presentations and the first deaths10.
The most common criteria for classifying the case as 
dengue fever with complications were cavitary effusions 
and thrombocytopenia. The onset of complications in 
individuals affected by dengue, such as cavitary effusions 
and thrombocytopenia, characterize the clinical severity. 
Consequently, accurate diagnosis of the complications 
presented by the patient requires not only a basis in 
clinical criteria but also the performance of complementary 
tests, including laboratory analyses and ultrasound 
examinations25,26. Thrombocytopenia can be caused by 
direct or indirect interaction of the virus with platelets, 
which is a constant finding in patients with severe forms 
of dengue27. In a study performed in Recife, the capital of 
Pernambuco State, platelet counts averaged 48,538/mm3 in 
patients who died28. In a study conducted in Ceará, a State 
in Northeastern Brazil, in 2003, patients who died had lower 
platelet counts than those with favorable outcomes, and 
their platelet count decreased progressively until death29.
In the 10-year period analyzed in this study, the 
viral serotype was isolated only in 47 cases. In a study30 
conducted for over 2 years in Manaus, the capital of 
Amazonas State, the serotype was identified in 41 cases, 
which demonstrates the difficulty of laboratory support 
for dengue epidemiological surveillance in São Luís. 
Additionally, the presence of three serotypes that were 
simultaneously isolated in 2007 (DENV-1, DENV-2 and 
DENV-3) has possibly contributed to the abrupt increase of 
severe cases, particularly in children <15 years old.
The simultaneous circulation of three serotypes 
(DENV-1, DENV-2 and DENV-4) was observed again 
in 2011, and there was a new increase in the number of 
cases and an increase in cases with clinical severity in 
children <15 years old. The circulation of three serotypes 
(DENV-1, DENV-2 and DENV-3) in Brazil since 2000 
and, more recently, the reintroduction of DENV-4, which is 
associated with the spread of its main vector, Aedes aegypti, 
in more than two-thirds of the country’s municipalities, 
Table 5 - Univariate and multivariate analysis of factors associated with severe dengue. São Luís, Maranhão, 2002 to 2011 
Variable
Non-adjusted Adjusted
OR 95% CI P value OR 95% CI P value
Male 1 1
Female 1.04 0.93-1.17 0.477 1.05 0.91-1.20 0.516
≥15 years old 1 1
<15 years old 3.01 2.66-3.41 0.001 3.11 2.70-3.60 <0.001
Rural area 1 1
Urban area 0.68 0.55-0.83 0.001 0.82 0.65-1.03 0.091
Race/skin color (black) 1 1
Race/skin color (caucasian) 1.47 1.09-1.99 0.012 1.30 0.95-1.78 0.103
Race/skin color (Asian) 0.64 0.32-1.28 0.213 0.60 0.30-1.21 0.153
Race/skin color (mixed) 1.17 0.88-1.54 0.271 0.96 0.72-1.28 0.769
Race/skin color (indigenous) 0.55 0.07-4.13 0.558 0.64 0.08-4.94 0.667
OR = odds ratio. CI = confidence interval. Source: SINAN.
Dias Júnior et al.
Rev Inst Med Trop São Paulo. 2017;59:e71Page 8 of 10
has contributed to the worsening of the epidemiological 
situation of the disease11.
The DENV-2 serotype was detected in all age groups, 
both in patients with severe dengue and in those who did not 
progress to severe dengue. According to Watts et al.31, an 
American genotype of the DENV-2 serotype isolated in Peru 
in 1995 was not related to the emergence of severe forms. 
However, a DENV-2 genotype from Southeast Asia was 
related to epidemics of more severe forms in 2008 in Brazil.
Together with two other serotypes, the DENV-2 serotype 
was isolated in the years with large increases in the number 
of cases, namely, in 2007 and 2011, both among severe and 
non-severe cases. In a study conducted in Rio de Janeiro in 
2001/2002, individuals affected by the DENV-3 serotype 
exhibited dengue with a greater clinical severity32. In 
Manaus, there was simultaneous circulation of serotypes 
DENV-1 and DENV-2 in 2006/2007, which facilitated the 
emergence of severe cases in children under 1530. In Ceará, 
DENV-2 became the predominant serotype in 2007 (84%) 
and 2008 (76.1%), followed by the increasing of dengue 
hemorrhagic fever incidence and hospitalization rate due 
to dengue among for children <10 years old33.
Most of the hospitalizations occurred in the first 
semester of each year. Studies conducted in 1999 in São 
Luis, Maranhão34, from 2002 to 2006 in Teresina, Piauí35, 
and from 2001 to 2002 in São Sebastião, São Paulo36, 
demonstrated that most dengue cases had also occurred in 
the first semester of each year.
Fever defervescence in dengue can last up to 7 days 
and, during this period, the patient may present signs that 
characterize complications and/or severity, which may 
explain the hospitalizations in the same period as the 
notifications. Kouri et al.37 reconstructed the natural history 
of dengue in children under 15 who died in Cuba in 1981 and 
found that the most important hemorrhagic manifestations 
occurred on the third day of disease, followed by shock on 
the fourth day and death on the fifth day.
Most hospitalizations were concentrated in the 
2005/2007 and 2010/2011 periods. Dengue severity was 
related to the consecutive/simultaneous circulation of two 
or more serotypes38.
In Brazil from 2000 to 2010, the co-circulation of 
multiple DENV serotypes and high dengue disease 
endemicity may be responsible for the increased occurrence 
of severe forms of dengue disease and increases in the 
numbers of dengue disease-related hospitalizations. In 
addition, increase in the number of severe dengue disease 
cases and a shift in age group predominance of severe forms 
observed during 2007/08 confirm that dengue disease must 
remain a public health priority18.
The high case-fatality rates found in this study may have 
been caused by the underreporting of severe cases, including 
the year 2005. Notably, the acceptable case-fatality rate 
of dengue fever should be less than 1% according to the 
WHO19. We found high case-fatality rates in children 
under 15 years in this study. In a study conducted in the 
city of Rio de Janeiro, most dengue deaths occurred in the 
<15 age group39. However, in a study conducted in the State 
of Bahia from 2001 to 2009, the majority of deaths occurred 
in the group >15 years old40. 
It is imperative to diagnose dengue during the early 
phase in order to provide information for the appropriate 
management of cases and to avoid complications41. 
Sensitivity and specificity tests are essential for the accurate 
laboratory diagnosis of DENV-infected patients41. RT–PCR 
has become a primary tool to detect the virus early in the 
course of illness; DENV can be detected in the blood (serum) 
of patients during the first 5 days of symptoms; current tests 
are between 80-90% sensitive, and more that 95% specific42. 
Solanke et al.41 found that on days 1-3 of the acute phase, 
the sensitivity and specificity of NS1 ELISA were 66.6% 
and 89.1%, while sensitivity and specificity of rapid NS1 
antigen were 55.5% and 92%, respectively. MAC-ELISA has 
a sensitivity and specificity of approximately 90% and 98%, 
respectively, but only when used five or more days after the 
onset of fever42. The main limitations of the study are inherent 
to the use of secondary data; not all cases were confirmed 
by the laboratory criterion and there is no information in the 
SINAN form about primary vs. secondary infection.
The following are strengths of this study: it included 
a large number of cases; it is one of the few studies on 
severe dengue in children in Brazil and it provides an 
analysis of secondary data from SINAN that may serve as 
a management tool, including the patient’s care.
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